Page 208

Bibliography

Abbott JD, Preston NW, Mackay RI. 1971. Agglutinin response to pertussis vaccination in the child. British Medical Journal 1:86-89.

Ada GL. 1990. The immunological principles of vaccination. Lancet 335:523-526.

Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M, Demelova M, Hejdova E. 1969. Comparative study of the reactogenicity and efficacy of different combined vaccines against diphtheria, pertussis and tetanus. Progress in Immunobiological Standardization 3:290-291.

Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M, Demelova M, Hejdova E. 1970. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus. Journal of Hygiene, Epidemiology, Microbiology and Immunology 14:88-101.

Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet 1:955-960.

Adler SP. 1982. The effects and side effects of vaccines. Virginia Medical Journal 109:410-411.

Aicardi J. 1989. Status epilepticus. Pediatrics 84:939-940.

Aicardi J, Chevrie JJ. 1975. Accidents neurologiques consecutifs a la vaccination contre la coqueluche. [Neurological complications following immunization against pertussis.] Archives Francaises de Pediatrie 32:309-317.

Alderslade R, Bellman MH, Rawson NSB, Ross EM, Miller DL. 1981. The National Childhood Encephalopathy Study: a report on 1000 cases of serious neurological disorders in infants and young children from the NCES research team. In: Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 208
Page 208 Bibliography Abbott JD, Preston NW, Mackay RI. 1971. Agglutinin response to pertussis vaccination in the child. British Medical Journal 1:86-89. Ada GL. 1990. The immunological principles of vaccination. Lancet 335:523-526. Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M, Demelova M, Hejdova E. 1969. Comparative study of the reactogenicity and efficacy of different combined vaccines against diphtheria, pertussis and tetanus. Progress in Immunobiological Standardization 3:290-291. Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M, Demelova M, Hejdova E. 1970. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus. Journal of Hygiene, Epidemiology, Microbiology and Immunology 14:88-101. Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet 1:955-960. Adler SP. 1982. The effects and side effects of vaccines. Virginia Medical Journal 109:410-411. Aicardi J. 1989. Status epilepticus. Pediatrics 84:939-940. Aicardi J, Chevrie JJ. 1975. Accidents neurologiques consecutifs a la vaccination contre la coqueluche. [Neurological complications following immunization against pertussis.] Archives Francaises de Pediatrie 32:309-317. Alderslade R, Bellman MH, Rawson NSB, Ross EM, Miller DL. 1981. The National Childhood Encephalopathy Study: a report on 1000 cases of serious neurological disorders in infants and young children from the NCES research team. In: Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint

OCR for page 208
Page 209 Committee on Vaccination and Immunisation. Department of Health and Social Security. London: Her Majesty's Stationery Office. Alford CA, Griffiths PD. 1983. Rubella. In: Remington JS, Klein JE, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W.B. Saunders Co. Alford CA, Neva, FA, Weller TH. 1964. Virologic and serologic studies on human products of conception after maternal rubella. New England Journal of Medicine 271:1275-1281. Alfrey AC. 1984. Aluminium intoxication. New England Journal of Medicine 310:1113-1115. Alfrey AC, LeGendre GR, Kaehny WD. 1976. The dialysis encephalopathy syndrome. New England Journal of Medicine 294:184-188. Alicata P, Castro A, Faro S, Motta S. 1988. Lymphocytes proliferation kinetics and SCE variation after rubella vaccination. Mutation Research 198:215-219. Allen AD. 1988. Is RA27/3 rubella immunization a cause of chronic fatigue? Medical Hypotheses 27:217-220. Al-Qudah AA, Shahar E, Logan WJ, Murphy EG. 1988. Neonatal Guillain-Barrè syndrome. Pediatric Neurology 4:255-256. Altmann P, Hamon C, Blair J, Dhanesha U, Cunningham J, Marsh F. 1989. Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity. Lancet 2:7-11. Ambrosch F, Wiedermann G. 1979. Changes of risk and benefit in immunization against pertussis and tuberculosis. In: International Symposium on Immunization, Brussels, 1978. Developments in Biological Standardization 43:85-90. American Academy of Pediatrics. 1944. Report of the Committee on Infectious Diseases: Pertussis. Evanston, IL: American Academy of Pediatrics. American Academy of Pediatrics. 1980. Consensus statement. Febrile seizures: long-term management of children with fever-associated seizures. Pediatrics 66:1009-1012. American Academy of Pediatrics, Committee on Infectious Diseases. 1982. Red Book update. Pediatrics 70:819-820. American Academy of Pediatrics. 1986. The Red Book. Report of the Committee on Infectious Diseases, 20th edition. Peter G, ed. Elk Grove, IL: American Academy of Pediatrics. American Academy of Pediatrics, Committee on Infectious Diseases. 1987. Family history of convulsions in candidates for immunization with pertussis-containing vaccines (diphtheria, tetanus, pertussis). Pediatrics 80:743-744. American Academy of Pediatrics. 1988. The Red Book. Report of the Committee on Infectious Diseases, 21st edition. Peter G, ed. Elk Grove, IL: American Academy of Pediatrics. American Academy of Pediatrics. 1990. Infectious disease expert delivers DTP testimony. AAP News (September):9, 18, 19. American Academy of Pediatrics. 1991a. The status of acellular pertussis vaccines: current perspective. AAP News (May):14-15, 23. American Academy of Pediatrics. 1991b. The relationship between pertussis vaccine and brain damage: reassessment. AAP News (May):18-19. American Journal of Diseases of Children. 1969. International conference on rubella immunization. 118:1-410.

OCR for page 208
Page 210 American Medical Association. 1984. Report of Ad Hoc Commission on Vaccines Injury Compensation. Chicago. American Medical Association, Ad Hoc Panel on Pertussis Vaccine Injury. 1985. Pertussis vaccine injury. Journal of the American Medical Association 254:30833085. American Psychiatric Association. 1968. Diagnostic and statistical manual of mental disorders, 2nd edition (DSM II). Washington, DC: American Psychiatric Association. American Psychiatric Association. 1980. Diagnostic and statistical manual of mental disorders, 3rd edition (DSM III). Washington, DC: American Psychiatric Association. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised (DSM III-R). Washington, DC: American Psychiatric Association. Amiel SA. 1976. The effects of Bordetella pertussis vaccine on cerebral vascular permeability. British Journal of Experimental Pathology 57:653-662. Amiel-Tison C. 1973. Neurologic disorders in neonates associated with abnormalities of pregnancy and birth. Current Problems of Pediatrics 3:3-37. Anderson EK. 1953. Serological studies on H. pertussis, H. parapertussis, and H. bronchisepticus. Acta Pathologica Microbiologica Scandinavica 33:202-224. Anderson EL, Belshe RB, Bartram J. 1985. Clinical evaluation of acellular pertussis DT vaccine in young children. Abstract E27. Presented at the 85th Annual Meeting of the American Society for Microbiology, Las Vegas. Anderson EL, Belshe RB, Bartram J, Gurwith M, Hung P, Levner M, Vernon SK. 1987. Clinical and serologic responses to acellular pertussis vaccine in infants and young children. American Journal of Diseases of Children 141:949-953. Anderson EL, Belshe RB, Bartram J. 1988. Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. Journal of Infectious Diseases 157:731-737. Anderson GR. 1976. Problems associated with the development and clinical testing of an improved pertussis vaccine. In: Perlman D, ed. Advances in Applied Microbiology, Vol. 20. Madison, WI: Academic Press. Anderson I, Morris D. 1950. Encephalopathy after combined diphtheria-pertussis inoculation. Lancet 1:537-539. Anderson R, May R. 1982. The logic of vaccination. New Scientist 96:410-415. Angell M. 1990. The interpretation of epidemiologic studies. New England Journal of Medicine 323:823-825. Annegers JF, Hauser WA, Shirts SB, Kurland LT. 1987. Factors prognostic of unprovoked seizures after febrile convulsions. New England Journal of Medicine 316:493498. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. 1988. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 38:1407-1410. Aoyama T, Murase Y, Kato T, Iwata T. 1985. Efficacy of an acellular pertussis vaccine in Japan. Journal of Pediatrics 107:180-183. Aoyama T, Hagiwara S, Murase Y, Kato T, Iwata T. 1986. Adverse reactions and antibody responses to acellular pertussis vaccine. Journal of Pediatrics 109:925930.

OCR for page 208
Page 211 Aoyama T, Murase Y, Gonda T, Iwata T. 1988. Type-specific efficacy of acellular pertussis vaccine. American Journal of Diseases of Children 142:40-42. Aoyama T, Goto R, Iwai H, Murase Y, Iwata T. 1990. Pertussis in the adult. In: Manclark CR, ed. Sixth International Symposium on Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services. Arai H, Sato Y. 1976. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochimica Biophysica Acta 444:765-782. Arima M, Fukuyama Y, Nagahata M, Okada R, Kubota T. 1959. The prompt reaction and delayed reaction of the central nervous system following immunization. Nihon Shonika Gakukai Zasshi [Journal of the Japanese Pediatric Association] 63:1298-1303. [in Japanese] Armitage P, Perry WLM. 1957. British standard for pertussis vaccine: its use in routine control of commercial vaccines. British Medical Journal 2:501-505. Arora S, Sanyal RK. 1968. The role of the adrenergic system in the mechanism of action of Bordetella pertussis vaccine. International Archives of Allergy 33:299305. Arora S, Sanyal RK, West GB. 1970. The sensitizing action of Bordetella pertussis vaccine. International Archives of Allergy 37:357-365. Ash D. 1982. Whooping cough immunization. Medical Journal of Australia 1:369370. Ashworth LAE, Irons LI, Dowsett AB. 1982. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infection and Immunity 37:1278-1281. Askelof P, Bartfai T. 1979. Effect of whooping-cough vaccine on cyclic-GMP levels in the brain. FEMS Microbiology Letters 6:223-225. Assaad F, Ljungars-Esteves L. 1985. Rubella—world impact. Reviews of Infectious Diseases 7:S29-S36. Au-Jensen M, Heron I. 1985. Is the acute encephalopathy test in mice suited for control of pertussis vaccines? Developments in Biological Standardization 61:447451. Au-Jensen M, Heron I. 1987. Synergistic teratogenic effect produced in mice by whole cell pertussis vaccine. Vaccine 5:215-218. Austin SM, Altman R, Barnes EK, Dougherty WJ. 1972. Joint reactions in children vaccinated against rubella. I. Comparison of two vaccines. American Journal of Epidemiology 95:53-58. Azeemuddin S. 1987. Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella. Clinical Pediatrics 26:318. Badgett JT, Rodgers GC. 1987. Safety and immunogenicity of a diphtheria-tetanuspertussis vaccine containing an acellular pertussis component. Southern Medical Journal 80:1075-1078. Baeva EA, Selezneva TS, Kucherovskaya TV, Auzinya AV, Glinskaya EV. 1986. Reactogenic properties of adsorbed diphtheria-pertussis-tetanus vaccine with the reduced content of antigens. Zhurnal Mikrobiologii Epidemiologii Immunobiologii 10:47-50. Bailey G. 1962. Carpal-tunnel syndrome (letter). British Medical Journal 1:1207.

OCR for page 208
Page 212 Baird H, Borofsky LG. 1957. Infantile myoclonic spasm. Journal of Pediatrics 50:332339. Baker RH. 1981. Pertussis immunisation and serious acute neurological illness in children (letter). British Medical Journal 282:1870. Baldini M. 1966. Idiopathic thrombocytopenic purpura. New England Journal of Medicine 274:1245-1251. Balfour HH, Balfour CL, Edelman CK, Rierson PA. 1976. Evaluation of Wistar RA27/3 rubella virus vaccine in children. American Journal of Diseases of Children 130:1089-1091. Balfour HH, Groth KE, Edelman CK. 1980. RA 27/3 rubella vaccine. American Journal of Diseases of Children 134:350-353. Banks WA, Kastin AJ. 1989. Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier. Neuroscience & Biobehavioral Reviews 13:47-53. Bannatyne RM, Cheung R. 1981. Reducing the endotoxic activity of pertussis vaccine. Journal of Hygiene (Cambridge) 87:377-381. Baraff LJ, Cherry JD. 1979. Nature and rates of adverse reactions associated with pertussis immunization. In: Manclark CR, Hill JD (eds). International Symposium on Pertussis. U.S. Department of Health, Education, and Welfare Publication No. (NIH) 79-1830. Washington, DC: U.S. Government Printing Office. Baraff LJ, Cherry JD, Cody CL, Manclark CR. 1980. Pertussis vaccine project: rates, nature and etiology of adverse reactions associated with DTP vaccine. Unpublished. Baraff LJ, Ablon WJ, Weiss RC. 1983. Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome. Pediatric Infectious Disease Journal 2:7-11. Baraff LJ, Cody CL, Cherry JD. 1984a. DTP-associated reactions: an analysis by injection site, prior reactions, and dose. Pediatrics 73:31-36. Baraff LJ, Leake RD, Burstyn DG, Payne T, Cody CL, Manclark CR, St. Geme JW. 1984b. Immunologic response to early and routine DTP immunization in infants. Pediatrics 73:37-42. Baraff LJ, Cherry JD, Cody CL, Marcy SM, Manclark CR. 1985. DTP vaccine reactions: effect of prior reactions on rate of subsequent reactions. Developments in Biological Standardization 61:423-428. Baraff LJ, Shields D, Beckwith L, Strome G, Marcy SM, Cherry JD, Manclark CR. 1988. Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics 81:789-794. Baraff LJ, Manclark CR, Cherry JD, Christenson P, Marcy M. 1989. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatric Infectious Disease Journal 8:502-507. Barkin RM, Pichicero ME. 1979. Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics 63:256-260. Barkin RM, Samuelson JS, Gotlin LP. 1984. DTP reactions and serologic response with a reduced dose schedule. Journal of Pediatrics 105:189-194. Barkin RM, Samuelson JS, Gotlin LP. 1985. Diphtheria and tetanus toxoids and

OCR for page 208
Page 213 pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule. Developments in Biological Standardization 61:297-307. Barnes EK, Altman R, Austin SM, Dougherty WJ. 1972. Joint reactions in children vaccinated against rubella. Study II: Comparison of three vaccines. American Journal of Epidemiology 95:59-66. Barnes JM, Hilton MJ. 1970. The value of the mouse toxicity test for screening pertussis vaccine. International Symposium on Pertussis, Bilthoven, 1969. Symposia Series in Immunobiological Standardization 13:180-184. Barrie H. 1983. Campaign of terror. American Journal of Diseases of Children 137:922-923. Bartley TD, Whiteley DW, Mar VL, Burns DL, Burnette WN. 1989. Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit. Proceedings of the National Academy of Sciences 86:8353-8357. Bartos HR. 1972. Thrombocytopenia associated with rubella vaccination. New York State Journal of Medicine 72:499. Bass JW. 1985. Pertussis: current status of prevention and treatment. Pediatric Infectious Diseases 4:614-619. Bassili WR, Stewart GT. 1976. Epidemiological evaluation of immunization and other factors in the control of whooping cough. Lancet 1:471-473. Battista RN, Lawrence RS, eds. 1988. Implementing Preventive Services. New York: Oxford University Press. Supplement to American Journal of Preventive Medicine 4(4). Baumann E, Binder E, Falk W, Huber EG, Kurz R, Rosanelli K. 1985. Development and clinical use of an oral heat-inactivated whole cell pertussis vaccine. Developments in Biological Standardization 61:511-516. Bayer AS. 1980. Arthritis related to rubella: a complication of natural rubella and rubella immunization. Postgraduate Medicine 67:131-134. Bayer WL, Sherman FE, Michaels RH, Szeto ILF, Lewis JH. 1965. Purpura in congenital and acquired rubella. New England Journal of Medicine 273:13621366. Becker RH. Pertussis immunisation and serious acute neurological illness in children. British Medical Journal 282:1870. Beckwith JB. 1973. The sudden infant death syndrome. Current Problems in Pediatrics 3:3-36. Becus-Laurentiu M, Szabo-Adorjan E, Pozsgi N, Szabo S. 1974. Etude histochimique de l'ovaire de ratte: l'effet du choc anaphylactique et du vaccin pertussis. Archives Roumaines de Pathologie Experimentale et de Microbiologie 33:97-106. Beghi E, Kurland LT, Mulder DW. 1982. Incidence of acute transverse myelitis in Rochester, Minnesota, 1970-1980, and implications with respect to influenza vaccine. Neuroepidemiology 1:176-188. Beghi E, Nicolosi AN, Kurland LT, Mulder DW, Hauser WA, Shuster L. 1984. Encephalitis and aseptic meningits, Olmsted County, Minnesota, 1950-1981. I. Epidemiology. Annals of Neurology 16:283-294. Beghi E, Kurland LT, Mulder DW, Nicolosi A. 1985. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Annals of Neurology 18:320323.

OCR for page 208
Page 214 Behan PO. 1977. Diffuse myelitis associated with rubella vaccination (letter). British Medical Journal 1:166. Behan PO. 1989. Report on the neurological complications of pertussis vaccination in children. August 1989. Unpublished. Behrman RE, Vaughan VC, eds. 1987. Nelson's Textbook of Pediatrics, 16th edition. Philadelphia: W.B. Saunders Co. Behrman S. 1981. Pertussis immunisation and serious acute neurological illness in children (letter). British Medical Journal 282:1871. Bell of Atri, Inc. 1990. Letter from J. Anthony Morris to Dean A. Blumberg, October 19, 1990. Submitted to Institute of Medicine Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Unpublished. Bellman MH. 1983. Serious acute neurological diseases of children: a clinical and epidemiological investigation with special reference to whooping cough disease and immunization. Unpublished thesis submitted for the degree of Doctor of Medicine, University of London. Bellman MH, Ross EM. 1985. Pertussis immunization and fits. In: Ross E, Reynolds E, eds. Paediatric Perspectives on Epilepsy. New York: John Wiley & Sons. Bellman MH, Ross EM, Miller DL. 1982. Reye's syndrome in children under three years old. Archives of Disease in Childhood 57:259-263. Bellman MH, Ross EM, Miller DL. 1983a. Infantile spasms and pertussis immunisation. Lancet 1:1031-1034. Bellman MH, Ross EM, Miller DL. 1983b. Pertussis vaccine and infantile spasms (letter). Lancet 2:278-279. Bellman MH, Rawson NSB, Wadsworth J, Ross EM, Cameron S, Miller DL. 1985. A developmental test based on the STYCAR sequences used in the National Childhood Encephalopathy Study. Child: Care, Health and Development 11:309-323. Benacerraf B, Kabat EA. 1950. A quantitative study of the Arthus phenomenon induced passively in the guinea pig. Journal of Immunology 64:1-19. Bender L. 1942. Post encephalitic behavior disorders in childhood. In: Bender L, ed. Encephalitis: A Clinical Study. New York: Grune & Stratton. Berenbaum MC, Ungar J, Stevens WK. 1960. Intracranial infection of mice with Bordetella pertussis. Journal of General Microbiology 22:313-322. Berg JM. 1958. Neurological complications of pertussis immunization. British Medical Journal 2:24-27. Berger SA, Ginsberg GM, Slater PE. 1990. Cost-benefit analysis of routine mumps and rubella vaccination for Israeli infants. Israel Journal of Medical Science 26:7480. Bergman RK, Munoz JJ. 1975. Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability. Journal of Allergy and Clinical Immunology 55:378-385. Bergman RK, Munoz JJ, Portis JL. 1978. Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis. Infection and Immunity 21:627-637. Berkow R, ed. 1987. Pertussis. Merck Manual of Diagnosis and Therapy, 15th edition. Rahway, NJ: Merck Sharpe & Dohme Research Laboratories.

OCR for page 208
Page 215 Berlin BS. 1983. Convulsions after measles immunization. Lancet 1:1380. Bernbaum JC, Daft A, Anolik R. 1985. Response of preterm infants to diphtheriatetanus-pertussis immunizations. Journal of Pediatrics 107:184-188. Bernier RH. 1982. Prospects for a new pertussis vaccine. In: Centers for Disease Control. Seventeenth Immunization Conference Proceedings. Washington, DC: U.S. Government Printing Office. Bernier RH, Frank JA, Nolan TF. 1981. Abscesses complicating DTP vaccination. American Journal of Diseases of Children 135:826-828. Bernier RH, Frank JA, Dondero TJ, Turner P. 1982. Diphtheria-tetanus toxoidspertussis vaccination and sudden infant deaths in Tennessee. Journal of Pediatrics 101:419-421. Berry PS, Cohen RA. 1990. Statement of Phillip S. Berry and Ralph A. Cohen to Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Institute of Medicine Public Meeting on Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, January 10, 1990. Unpublished. Best JM, Banatvala JE, Bowen JM. 1974. New Japanese rubella vaccine: comparative trials. British Medical Journal 3:221-224. Best JM, Banatvala JE, Morgan-Capner P, Miller E. 1989. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. British Medical Journal 299:773-775. Bishop WB, Carlton RF, Sanders LL. 1966. Diffuse vasculitis and death after hyperimmunization with pertussis vaccine: report of a case. New England Journal of Medicine 274:616-619. Black FL, Lamm SH, Emmons JE, Pinheiro FP. 1976. Reactions to rubella vaccine and persistence of antibody in virgin-soil populations after vaccination and wild-virus-induced immunization. Journal of Infectious Diseases 133:393-398. Black NA, Kurtz JB, Lacey A, Parsons A, McWhinney N, Mayon-White RT. 1983. Post-partum rubella immunisations: a controlled trial of two vaccines. Lancet 2:990-992. Black WJ, Munoz JJ, Peacock MG, Schad PA, Cowell JL, Burchall JJ, Lim M, Kent A, Steinman L, Falkow S. 1988. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by B. pertussis. Science 240:656-659. Blackwelder W, Olin P, Storsaeter J. 1988. Efficacy trial in Sweden: design and results. Presented at NIAID/FDA/CDC/USAID Status of Acellular Pertussis Vaccines—Swedish Trial Update, Bethesda, Maryland, Febuary 8-9, 1988. Blanc S, Leuenberger P, Berger J-P, Brooke EM, Schelling J-L. 1979. Judgments of trained observers on adverse drug reactions. Clinical Pharmacology and Therapeutics 25:493-498. Blattner RJ, Feigin RD. 1986. Diphtheria, pertussis, and tetanus (DTP) immunization local reactions do not predict central nervous system reactions. Pediatrics 78:1168-1169. Bleck TP. 1990. Time course of adverse events following exposure to known neurotoxic and immunotoxic agents. Presentation for Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Institute of Medicine Workshop on Possible Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, May 14, 1990. Unpublished.

OCR for page 208
Page 216 Blennow M, Granstrom M. 1989a. Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants. Pediatrics 84:62-67. Blennow M, Granstrom M. 1989b. Sixteen-month follow-up of antibodies to pertussis toxin after primary immunization with acellular or whole cell vaccine. Pediatric Infectious Disease Journal 8:621-625. Blennow M, Granstrom M. 1990. Long term serologic follow-up after pertussis immunization. Pediatric Infectious Disease Journal 9:21-26. Blennow M, Granstrom M, Jaatmaa E, Olin P. 1988. Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial. Pediatrics 82:293-299. Bloom BR. 1989. Vaccines for the third world. Nature 342:115-120. Blumberg DA, Morgan CA, Lewis K, Leach C, Holtzman A, Levin SR, Baraff LJ, Cherry JD. 1988. An ongoing surveillance study of persistent crying and hypotonic-hyporesponsive episodes following routine DTP immunization: a preliminary report. Tokai Journal of Experimental and Clinical Medicine 13(Suppl.):133136. Blumberg DA, Mink CM, Lewis K, Chatfield P, Leach C, Smith LP, Christenson PD, Guravita L, Steinfeld MBJ, March SM, Levin SR, Baraff LJ, Schonfeld N, Cherry JD. In press. Pathophysiology of reactions associated with pertussis vaccine. Developments in Biological Standardization. Blumstein GI, Kreithen H. 1966. Peripheral neuropathy following tetanus toxoid administration. Journal of the American Medical Association 198:1030-1031. Bobele GB, Bodensteiner JB. 1990. Infantile spasms. Neurologic Clinics 8:633-645. Bokoch GM, Katada T, Northrup JK, Hewlitt EL, Gilman AG. 1983. Identification of the predominant substrate for ADP-ribosylation by islet cell activating protein. Journal of Biochemistry 258:2072-2075. Bond D. 1985. Former nurse sues vaccine manufacturer. Spokesman-Review, Spokane, WA, February 7, 1985, p.6. Bordet J, Gengou O. 1906. Le microbe de la coqueluche. Annales Institut Pasteur 20:731-741. Bottiger L, Westerholm B. 1973. Drug-induced blood dyscrasias in Sweden. British Medical Journal 3:339-343. Bouvier-Colle MH, Flahaut A, Messiah A, Jougla E, Hatton F. 1989. Sudden infant death and immunization: an extensive epidemiological approach to the problem in France—winter 1986. International Journal of Epidemiology 18:121-126. Bower BD, Jeavons PM. 1960. Complications of immunization. British Medical Journal 2:1453. Bowie C. 1990. Lessons from the pertussis vaccine court trial. Lancet 335:397-399. Bracken MB. 1989. Potential biases related to date of onset assignment in the (British) National Childhood Encephalopathy Study. Institute of Medicine Workshop on the National Childhood Encephalopathy Study, Washington, DC, November 7-8, 1989. Unpublished. Bradford WL, Day E, Martin F. 1949. Humoral antibody formation in infants aged one to three months injected with a triple (diphtheria-tetanus-pertussis) alumprecipitated antigen. Pediatrics 4:711-717.

OCR for page 208
Page 217 Braginskaya VP, Sokolova AF, Ozeretskovsky NA. 1980. Post-vaccination neurological complications in children. Zhurnal Nevropatologii Psikhiatrii 80:199-203. Brahams D. 1986. Medicine and the law: does pertussis vaccine cause brain damage? Lancet 1:1284. Brahams D. 1988. Pertussis vaccine: court finds no justification for association with permanent brain damage. Lancet 1:837. Brahams D. 1990. Medicine and the law: pertussis vaccine litigation. Lancet 335:905906. Brauer H. 1988. Are we sweeping DTP contraindications under the rug? (letter). American Journal of Diseases of Children 142:698. Brewis M, Poskanzer DC, Rolland C, Miller H. 1966. Neurological disease in an English city. Acta Neurologica Scandinavica 42(Suppl. 24):9-89. Brink EW. 1982. Pertussis update. In: Centers for Disease Control. Seventeenth Immunization Conference Proceedings. Washington, DC: U.S. Government Printing Office. British Medical Journal. 1974. Vaccination against whooping cough (editorial). 3:539-540. British Medical Journal. 1981. Pertussis vaccine (editorial). 282:1563-1564. British Medical Journal. 1986. The law tries to decide whether whooping cough vaccine causes brain damage: Professor Gordon Stewart gives evidence. 292:12641266. British Medical Journal. 1990. Wellcome to stop vaccine production. 301:777. British National Formulary. 1988. London: British Medical Association/Pharmaceutical Society of Great Britain. Brodribb HS. 1963. Rubella (1962) in three boarding schools: its complications and types. British Journal of Clinical Practice 17:726-730. Brody JA. 1966. The infectiousness of rubella and the possibility of reinfection. American Journal of Public Health 56:1082-1087. Brody M, Sorley RG. 1947. Neurologic complications following the administration of pertussis vaccine. New York State Journal of Medicine 47:1016-1017. Broome CV, Fraser DW. 1981. Pertussis in the United States, 1979: a look at vaccine efficacy. Journal of Infectious Diseases 144:187-190. Broome CV, Fraser DW, English WJ. 1979. Pertussis: diagnostic methods and surveillance. In: Manclark CR, Hill JC, eds. 1979. International Symposium on Pertussis. U.S. Department of Health, Education, and Welfare Publication No. (NIH) 79-1830. Washington, DC: U.S. Government Printing Office. Broome CV, Preblud SR, Bruner B, McGowan JE, Hayes PS, Harris PR, Elsea W, Fraser DW. 1981. Epidemiology of pertussis, Atlanta, 1977. Journal of Pediatrics 98:362-367. Brown PE. 1981. Effect of vaccination on severity and dissemination of whooping cough (letter). British Medical Journal 283:60. Brunell P. 1983. Impact of litigation on immunization of children. Pediatrics 72:822823. Bryan H. 1988. Home monitoring in infants at risk for SIDS. In: Harper RM, Hoffman HJ, eds. Sudden Infant Death Syndrome Risk Factors and Basic Mechanisms. New York: PMA Publishing Corp. Bryceson ADM. 1976. Clinical pathology of the Jarisch-Herxheimer reaction. Journal of Infectious Diseases 133:696-704.

OCR for page 208
Page 218 Buchanan D. 1946. Convulsions in infancy and childhood. Medical Clinics of North America 30:163-171. Bui-Authier F, Martaguet B, Ainciburru PM, Codognet C, Sandler B. 1978. Syndrome de West et vaccination anticoquelucheuse. [West's syndrome and vaccination against whooping cough.] Bordeaux Medical 11:471-475. Burnet M, White DO. 1972. Natural History of Infectious Disease, 4th edition. Cambridge: University Press. Burnette WN. 1990. The advent of recombinant pertussis vaccines. Bio/Technology 8:1002-1005. Burnette WN, Cieplak W, Mar VL, Kaljot KT, Sato H, Keith JM. 1988a. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. Science 242:72-74. Burnette WN, Mar VL, Cieplak W, Morris CF, Kaljot KT, Sato H, Keith JM. 1988b. Toward development of a recombinant pertussis vaccine. In: Technological Advances in Vaccine Development. New York: Alan R. Liss, Inc. Burnette WN, Mar VL, Cieplak W, Morris CF, Kaljot KT, Marchitto KS, Sachdev RK, Locht C, Keith JM. 1988c. Direct expression of Bordetella pertussis toxin subunits to high levels in Escherichia coli. Bio/Technology 6:699-706. Burnette WN, Bartley TD, Whiteley DW, Mar VL, Cieplak W, Keith JM, Burns DL. 1989a. Recombinant analogs of pertussis toxin S1 subunit. In: Vaccines 89. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. Burnette WN, Whiteley DW, Mar VL, Burns DL, Kaslow HR, Cieplak W, Keith JM, Bartley TD. 1989b. Developments toward a recombinant pertussis vaccine. In: Atassi MZ, ed. Immunobiology of Proteins and Peptides V. New York: Plenum Publishing Corp. Burns DL, Hausman SZ, Witvliet MH, Brennan MJ, Poolman JT, Manclark CR. 1988. Biochemical properties of pertussis toxin. Tokai Journal of Experimental and Clinical Medicine 13(Suppl.):181-185. Butler NR, Voyce MA, Burland WL, Hilton ML. 1969. Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus and pertussis vaccines for the immunisation of infants. British Medical Journal 1:663-666. Butler NR, Golding J, Haslum M, Stewart-Brown S. 1982. Recent findings from the 1970 child health and education study: preliminary communication. Journal of the Royal Society of Medicine 75:781-784. Byers RK, Moll FC. 1948. Encephalopathies following prophylactic pertussis vaccination. Pediatrics 1:437-457. Byers RK, Rizzo ND. 1950. A follow-up study of pertussis in infancy. New England Journal of Medicine 242:887-891. Byrne EB, Ryan JM, Randolph MF, Horstmann DM. 1969. Live attenuated rubella virus vaccines in young adult women. American Journal of Diseases of Children 118:234-236. Cadoz M, Arminjon F, Quentin-Miller MS, Armand J. 1986. Safety and immunogenicity of Merieux acellular pertussis vaccines in adult volunteers. In: Workshop on Acellular Pertussis Vaccines. Transcript. Bethesda, MD: U.S. Department of Health and Human Services. Cameron J. 1976. Problems associated with the control testing of pertussis vaccine. Advances in Applied Microbiology 20:57-80.

OCR for page 208
Page 272 Stewart GT. 1982. ABC of 1 to 7: whooping cough (letter). British Medical Journal 284:1263. Stewart GT. 1983a. Reactions to pertussis vaccine (letter). Lancet 1:1217-1218. Stewart GT. 1983b. Whooping cough and pertussis vaccine (letter). British Medical Journal 287:287-289. Stewart GT. 1985. Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83. Developments in Biological Standardization 61:395-405. Stewart GT. 1990. Safety of pertussis vaccine. Lancet 335:913-914. Stewart GT, Wilson J. 1981. Pertussis vaccine and serious acute neurological illness in children (letter). British Medical Journal 282:1968-1969. Stewart-Harris C. 1981. Pertussis vaccine (letter). British Medical Journal 283:494. Stickl H, Schweier P, Van Thiel D. 1976. Preliminary results with an oral application of killed pertussis bacteria in newborn infants. Fourteenth Congress of the International Association of Biological Standardization, 1975. Developments in Biological Standardization 33:54-56. Still GF. 1902. The Coulstonian lectures on some abnormal physical conditions in children. Lancet 1:1008-1012, 1077-1082, 1163-1168. Storsaeter J, Olin P, Renemar B, Lagergard T, Norberg R, Romanus V, Tiru T. 1988. Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. Pediatric Infectious Disease Journal 7:637-645. Storsaeter J, Hallander HO, Farrington CP. 1990a. Evaluation of laboratory methods used for the diagnosis of pertussis infection and disease in the Vaccine Efficacy Trial in Sweden. In: Manclark CR, ed. Sixth International Symposium on Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services. Storsaeter J, Hallander H, Farrington CP, Olin P, Mollby R, Miller E. 1990b. Secondary analyses of the efficacy of two acellular pertussis vaccines in a Swedish phase III trial. Vaccine 8:457-461. Stott NCH, Davis RH. 1981. Pertussis vaccination and pseudo whooping cough (letter). British Medical Journal 282:1870-1871. Stout MG. 1988. U.S. clinical trials with Takeda acellular pertussis vaccine. Tokai Journal of Experimental and Clinical Medicine 13(Suppl.):21-28. Strauss AA, Lehtinen LE. 1947. Psychopathology and Education in the Brain-Injured Child. New York: Grune & Stratton. Ström J. 1960. Is universal vaccination against pertussis always justified? British Medical Journal 2:1184-1186. Ström J. 1967a. Social development and declining incidence of some common epidemic diseases in children: a study of the incidence in different age groups in Stockholm. Acta Pediatrica Scandinavica 56:159-163. Ström J. 1967b. Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden, 1959-1965. British Medical Journal 4:320-323. Ström J. 1970. Reactions of a cerebral nature in conjunction with triple vaccination in Sweden. International Symposium on Pertussis, Bilthoven, 1969. Symposia Series in Immunobiological Standardization 13:157-160.

OCR for page 208
Page 273 Stronk MG, Pittman M. 1955. The influence of pertussis vaccine on histamine sensitivity of rabbits and guinea pigs and on the blood sugar in rabbits and mice. Journal of Infectious Diseases 96:152-161. Stuart-Harris CH. 1979. Experiences of pertussis in the United Kingdom. In: Manclark CR, Hill JC, eds. International Symposium on Pertussis. U.S. Department of Health, Education, and Welfare Publication No. (NIH) 79-1830. Washington, DC: U.S. Government Printing Office. Stuart-Harris CH. 1981. Pertussis vaccine (letter). British Medical Journal 283:494. Stuart-Smith S. 1988. Judgment in Loveday vs. Renton & Wellcome. Royal Courts of Justice, London, March 29-30, 1988. Study of Neurologic Illness in Children. 1990. Case reports. Unpublished. Suffredini AF, Harpel PC, Parrillo JE. 1989a. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. New England Journal of Medicine 320:1165-1172. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. 1989b. The cardiovascular response of normal humans to the administration of endotoxin. New England Journal of Medicine 321:280-287. Sugarman SD. 1990. The need to reform personal injury law leaving scientific disputes to scientists. Science 248:823-827. Sullivan CE. 1988. Upper airway function and sleep apnea: relevance for unexpected death in infancy. In: Harper RM, Hoffman HJ, eds. Sudden Infant Death Syndrome Risk Factors and Basic Mechanisms. New York: PMA Publishing Corp. Sutherland JA. 1953. Encephalopathy following diphtheria-pertussis inoculation. Archives of Disease in Childhood 28:149-150. Sutter RW, Cochi SL, Farizo KM, Zell ER. 1990. Pertussis hospitalizations and mortality, United States, 1985-87: evaluation of the completeness of national reporting. In: Manclark CR, ed. Sixth International Symposium on Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services. Swartz TA, Klingberg W, Goldwasser RA, Klingberg MA, Goldblum N, Hilleman MR. 1971. Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine. American Journal of Epidemiology 94:246-251. Syukuda Y, Watanabe H, Suehara A, Fujii S, Kuno-Sakai H, Kimura M. 1988. Aerosol infection test for evaluation of pertussis vaccine. Tokai Journal of Experimental and Clinical Medicine 13(Suppl.):71-77. Szabo-Adorjan E, Pozsgi N. 1969. Effect of anaphylactic shock and pertussis vaccination on the oestrus cycle in rats and mice. Archives Roumaines de Pathologie Experimentale et de Microbiologie 28:437-444. Szatmari P, Tuff L, Finlayson AJ, Bartolucci G. 1990. Aspergers syndrome and autism—neurocognitive aspects. Journal of the American Academy of Child and Adolescent Psychiatry 29:130-136. Szentivanyi A, Fishel CW, Talmage D. 1963. Adrenaline mediation of histamine and serotonin hyperglycemia in normal mice and the absence of adrenaline-induced hyperglycemia in pertussis sensitized mice. Journal of Infectious Diseases 113:86-98. Tabachnick II, Gulbenkian A. 1969. Adrenergic changes due to pertussis: insulin, glucose and free fatty acids. European Journal of Pharmacology 7:186-195.

OCR for page 208
Page 274 Tada T, Okumura K, Ochiai T, Iwasa S. 1972. Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. II. Adjuvant effect of the production of reaginic antibody in the rat. International Archives of Allergy 43:207-216. Taggart C. 1988. Judge must rule again on vaccine: company says revealing recipe would be ruinous. Spokesman-Review, Spokane, Washington, October 14, 1988. Taranger J. 1982. Mild clinical course of pertussis in Sweden. Lancet 2:1360. Taranger J, Wiholm BE. 1987. Litet antal biverkningar rapporterade efter vaccination mot massling-passjuka-roda hund. Lakartidningen 84:948-950. Tardieu M. 1988. Les complications neurologiques des vaccinations. Gazette Medicale 95:27-30. Taylor EM, Emery JL. 1982. Immunisation and cot deaths (letter). Lancet 2:721. Taylor FM. 1952. Myoclonic seizures in infancy and childhood. Texas State Journal of Medicine 48:647-649. Terlingen JBA, Peters PWJ, Walvoort HC. 1984. A biphasic serum glucose response in mice to inoculation with pertussis vaccine. Journal of Biological Standardization 12:151-157. Thach BT. 1986. Sudden infant death syndrome: old causes rediscovered? (letter). New England Journal of Medicine 315:126-128. Thacker SB. 1988. Meta-analysis: a quantitative approach to research integration. Journal of the American Medical Association 259:1685-1689. Thier SO. 1968. Importance of the single case. New England Journal of Medicine 278:1347. Thoman ME. 1990. The clinical composite of severe pertussis vaccine reactions following DPT vaccine inoculation(s). Institute of Medicine Public Meeting on Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, January 10, 1990. Unpublished. Thompson GR, Ferreyra A, Brackett RG. 1971. Acute arthritis complicating rubella vaccination. Arthritis and Rheumatism 14:19-26. Thompson GR, Weiss JJ, Shillis JL, Brackett RG. 1973. Intermittent arthritis following rubella vaccination: a three year follow-up. American Journal of Diseases of Children 125:526-530. Thompson J. 1985. Whooping cough: helping parents assess the risks (editorial). Health Visitor 58:277. Thorndike RL. 1963. The Concepts of Over- and Under-Achievement. New York: Bureau of Publications, Teachers College, Columbia University. Tilelli JA, Manniello RL. 1990. Pertussis vaccine encephalopathy (letter). Journal of the American Medical Association 264:2385. Times (London). 1988. Evidence fails to prove vaccine causes brain damage. March 31, 1988, Law Report, p. 18. Tingle A. 1990. Evidence linking rubella vaccines to chronic arthritis. Presentation for Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Institute of Medicine Workshop on Possible Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, May 14, 1990. Unpublished. Tingle A. 1991. Personal communication to Institute of Medicine Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Tingle AJ, Kettyls DM, Ford DK. 1978a. Arthritis following rubella immunization:

OCR for page 208
Page 275 prospective serologic assessment. Annals of the Royal College of Physicians and Surgeons of Canada 11:96. Tingle AJ, Price GF, Ford DK. 1978b. Chronic recurrent joint manifestations following rubella immunization: clinical and immunologic studies in 6 adult females. Annals of the Royal College of Physicians and Surgeons of Canada 11:96. Tingle AJ, Ford DK, Price GE, Kettyls DWG. 1979a. Prolonged arthritis in identical twins after rubella immunization (brief report). Annals of Internal Medicine 90:203-204. Tingle AJ, Kettyls GDM, Ford DK. 1979b. Studies on vaccine-induced rubella arthritis: serologic findings before and after immunization. Arthritis and Rheumatism 22:400-402. Tingle AJ, Yang T, Allen M, Kettyls GD, Larke RP, Schulzer M. 1983. Prospective immunological assessment of arthritis induced by rubella vaccine. Infection and Immunity 40:22-28. Tingle AJ, Pot CH, Chantler JK. 1984. Prolonged arthritis, viraemia, hypogammaglobulinaemia, and failed seroconversion following rubella immunisation (letter). Lancet 1:1475-1476. Tingle AJ, Chantler JK, Kettyls GD, Larke RPB, Schulzer M. 1985a. Failed rubella immunization in adults: association with immunologic and virological abnormalities. Journal of Infectious Diseases 151:330-336. Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK. 1985b. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. Journal of Infectious Diseases 152:606-612. Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler JK. 1986. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Annals of the Rheumatic Diseases 45:110-114. Tingle AJ, Pot KH, Yong FP, Puterman ML, Hancock EJ. 1989. Kinetics of isotype-specific humoral immunity in rubella vaccine-associated arthropathy. Clinical Immunology and Immunopathology 53:S99-S106. Tobin JOH. 1971. Rubella vaccination of postpartum women and of adolescents in the northwest of England. Canadian Journal of Public Health 62:64-67. Tokai University, Department of Pediatrics. 1988. 5th International Symposium on Pertussis. Abstracts. September 22-23, 1988, Copenhagen, Denmark. Tondury G, Smith DW. 1965. Fetal rubella pathology. Journal of Pediatrics 68:867-879. Tonz O, Bajc S. 1980a. Zerebrale Krampfanfalle nach Pertussis-Impfung. [Convulsions after whooping cough vaccination.] Schweizerische Medizinische Wochenschrift 110:1965-1971. Tonz O, Bajc S. 1980b. Krampfanfalle und Enzephalopathien nach Pertussis-Impfung (Di-Te-Per). Helvetica Paediatrica Acta 35(Suppl. 45):20. Toomey JA. 1949. Reactions to pertussis vaccine. Journal of the American Medical Association 139:448-450. Torch WC. 1982. Diphtheria-pertussis-tetanus (DPT) immunization: a potential cause of the sudden infant death syndrome (SIDS) (abstract). American Academy of Neurology, 34th Annual Meeting, April 25-May 1. Neurology 32(4, part 2):A169-170.

OCR for page 208
Page 276 Torch WC. 1986. Characteristics of diphtheria-pertussis-tetanus (DPT) postvaccinal deaths and DPT-caused sudden infant death syndrome (SIDS): a review (abstract). Neurology 36(Suppl. 1): 148. Townsend JJ, Baringer JR, Wolinsky JS, Malamud N, Mednick JP, Panitch HS, Scott RA, Oshiro L, Cremer NE. 1975. Progressive rubella panencephalitis: late onset after congenital rubella. New England Journal of Medicine 292:990-993. Toyota T, Kai Y, Kakizaki M, Sakai A, Goto Y, Yajima M, Ui M. 1980. Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies). Tohoku Journal of Experimental Medicine 130:105-116. Trollfors B. 1984. Bordetella pertussis whole cell vaccines: efficacy and toxicity. Acta Paediatrica Scandinavica 73:417-425. Trollfors B, Rabo E. 1981. Whooping cough in adults. British Medical Journal 283:696-697. Tsairis P, Dick PJ, Mulder DW. 1972. Natural history of brachial plexus neuropathy. Archives of Neurology 27:109-117. Tsuboi T. 1977. Genetic aspects of febrile convulsions. Human Genetics 38:169-173. Tsuchiuia S, Kagawa K, Fukuyama Y. 1978. Critical evaluation of the role of immunisation as an etiological factor in infantile spasms (second report). Brain and Development 3:171. Tuomanen E. 1986. Piracy of adhesins: attachment of superinfection pathogens to respiratory cilia by secreted adhesins of Bordetella pertussis. Infection and Immunity 54:905-908. Tuomanen E, Weiss A. 1985. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. Journal of Infectious Diseases 152:118-125. Tuomanen E, Weiss A, Rich R, Zak F, Zak O. 1985. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia. Developments in Biological Standardization 61:197-204. Ueoka K. 1979. Clinical and electroencephalographic study in febrile convulsions, with special reference to follow-up study. Brain and Development 1:196. Urisu A, Cowell JL, Manclark CR. 1986. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infection and Immunity 52:695-701. U.S. Department of Health and Human Services. 1981. Estimated Economic Costs of Selected Medical Events Known or Suspected to Be Related to the Administration of Common Vaccines. NCHSR Research Summary Series. DHHS Publication No. (PHS) 81-3272. Washington, D.C. U.S. Department of Health and Human Services. 1988. Status of Acellular Pertussis Vaccines & Swedish Trial Update. Transcript of a workshop held February 8-9, 1988, Bethesda, MD. U.S. Office of Education. 1977. Assistance to states for education for handicapped children: procedures for evaluating specific learning disabilities. Federal Register 42:62082-62085. U.S. Preventive Services Task Force. 1989. Guide to Clinical Preventive Services. Washington, D.C.: U.S. Government Printing Office.

OCR for page 208
Page 277 Valdes-Dapena M. 1990. Evidence linking pertussis vaccines to sudden infant death syndrome (SIDS). Presentation for Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Institute of Medicine Workshop on Possible Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, May 14, 1990. Unpublished. Valensin PE, Rossolini GM, Cusi MG, Zanchi A, Cellesi C, Rossolini A. 1987. Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine. Vaccine 5:289-294. Valman HB. 1980. Contraindications to immunisation. British Medical Journal 280: 1138-1139. Valman HB. 1982. ABC of 1 to 7: whooping cough. British Medical Journal 284:886-887. Van den Berg BJ, Yerushalmy J. 1969. Studies on convulsive disorders in young children. I. Incidence of febrile and nonfebrile convulsions by age and other factors. Pediatric Research 3:298-304. Van Heuven-Nolsen D, Schoute E, Verdouw PD, De Wildt DJ, Nijkamp FP. 1989. In vivo beta2-adrenoceptor hyporesponsiveness in the cardiovascular system of the pig after Bordetella pertussis. European Journal of Pharmacology 162:135-141. Veale H. 1866. History of an epidemic of rothein, with observation on its pathology. Edinburgh Medical Journal 12:404-414. Vellutino FR. 1978. Toward an understanding of dyslexia: psychological factors in specific reading disability. In: Benton AL, Pearl D, eds. Dyslexia: An Appraisal of Current Knowledge. New York: Oxford University Press. Vellutino FR. 1979. Dyslexia: Theory and Research. Cambridge: MIT Press. Venulet J, Ciucci A, Berneker GC. 1980. Standardized assessment of drug-adverse reaction associations—rationale and experience. International Journal of Clinical Pharmacology, Therapy and Toxicology 18:381-388. Venulet J, Berneker GC, Ciucci AG, eds. 1982. Assessing Causes of Adverse Drug Reactions. New York: Academic Press. Vergani D, Morgan-Capner P, Davies ET, Anderson AW, Tee DEH, Pattison JR. 1980. Joint symptoms, immune complexes, and rubella (letter). Lancet 2:321-322. Vertes C, Gonczy S, Lendvay N, Debreczeni LA. 1987. A model for experimental asthma: provocation in guinea-pigs immunized with Bordetella pertussis. Bulletin of European Physiopathology and Respiration 23(Suppl. 10): 11 s-113s. Vesper J, Dietze RA. 1974. Zur Problematik der Verhutung, Erfassung und Begutachtung von neurogenen Impfschaden im Kindesalter aus klinischer und rechtlicher Sicht. Psychiatrie Neurologie und Medizinische Psychologie 26:685-692. Vesselinova-Jenkins CK. 1985. A live vaccine against pertussis. Developments in Biological Standardization 61:517-524. Villarejos VM, Arguedas JA, Hernandez GC, Buynak EB, Hilleman MR. 1973. Clinical laboratory evaluation of rubella virus vaccine given to postpartum women without pregnancy preventive. Obstetrics and Gynecology 42:689-695. Volkmar FR, Cohen DJ. 1986. Pervasive developmental disorders. In: Cavenar JO, ed. Psychiatry, Vol. 2. Philadelphia: J.B. Lippincott Co. Volpe JJ, ed. 1987. Neurology of the Newborn, 2nd ed. Philadelphia: W.B. Saunders.

OCR for page 208
Page 278 von Wehren U, von Torklus D. 1983. Arthritis nach Roteln-Impfung. [Arthritis following rubella immunization]. Zeitschrift fuer Orthopaedie und Ihre Grenzgebeite 121:749-750. Waight PA, Pollock TM, Miller E, Coleman EM. 1983. Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. Archives of Disease in Childhood 58:921-923. Walker A. 1990. Evidence linking pertussis vaccines to sudden infant death syndrome (SIDS). Presentation for Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Institute of Medicine Workshop on Possible Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, May 14, 1990. Unpublished. Walker A, Rees L. 1985. Mythical contraindications to vaccination (letter). Lancet 1:994. Walker AM, Jick H, Perera DR, Thompson RJ, Knauss TA. 1987. Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. American Journal of Public Health 77:945-951. Walker AM, Jick H, Perera DR, Knauss TA, Thompson RS. 1988a. Neurologic events following diphtheria-tetanus-pertussis immunization. Pediatrics 81:345-349. Walker AM, Martin-Moreno JM, Artalejo FR. 1988b. Odd man out: a graphical approach to meta-analysis. American Journal of Public Health 78:961-966. Wallace RB, Libert P, Ibrahim M, Isacson P. 1972. Joint symptoms following an area-wide rubella immunization campaign: report of a survey. American Journal of Public Health 62:658-661. Wardlaw AC. 1988a. Laboratory aspects of the U.K. pertussis vaccine test case. In: Mebel S, Stompe H, Drescher M, Rustenbach S. FEMS-Symposium Pertussis, Proceedings of the Conference Organized by the Society of Microbiology and Epidemiology of the German Democratic Republic, Berlin, April 20-22, 1988. Wardlaw AC. 1988b. Animal models for pertussis vaccine neurotoxicity. Abstract from the 5th International Symposium on Pertussis, Copenhagen, Denmark, September 22-23, 1988. Wardlaw AC. 1988c. Animal models for pertussis vaccine neurotoxicity. Tokai Journal of Experimental and Clinical Medicine 13(Suppl.):171-175. Wardlaw AC, Parton R. 1983a. Pertussis vaccine. In: Easmon CSF, Jeljaszewicz J, eds. Medical Microbiology, Vol. 2. New York: Academic Press. Wardlaw AC, Parton R. 1983b. Bordetella pertussis toxins. Pharmacology of Therapeutics 19:1-53. Wardlaw AC, Parton R, eds. 1988. Pathogenesis and Immunity in Pertussis. New York: John Wiley & Sons. Wardlaw AC, Boorman L, Reid R. 1971. Assay of endotoxin by the hypothermic response of mice. British Journal of Experimental Pathology 52:198-208. Wassilak SGF, Smith GS, Garbe PL, Burstyn DG, Manclark CR. 1983. Pertussis outbreak in a Colorado high school: use of a new ELISA (abstract no. 725). In: Program and Abstracts of the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology. Wehrle PF. Injury associated with the use of vaccines. 1985. Clinical Therapeutics 7:282-284.

OCR for page 208
Page 279 Weibel RE, Stokes J, Buynak EB, Hilleman MR. 1969. Live rubella vaccines in adults and children. American Journal of Diseases of Children 118:226-229. Weibel RE, Stokes J, Buynak EB, Hilleman MR. 1972. Influence of age on clinical response to HPV-77 duck rubella vaccine. Journal of the American Medical Association 222:805-807. Weibel RE, Stokes J, Buynak EB, Hilleman MR. 1969. Rubella vaccination in adult females. New England Journal of Medicine 280:682-685. Weibel RE, Villarejos VM, Klein EB, Buynak EB, McLean AA, Hilleman MR. 1980. Clinical and laboratory studies of live attenuated RA 27/3 and HPV 77-DE rubella virus vaccines. Proceedings of the Society for Experimental Biology and Medicine 165:44-49. Weigle K. 1989. Case definition: inclusion of cases with other potential etiologies for case presentation. Institute of Medicine Workshop on the National Childhood Encephalopathy Study, Washington, DC, November 7-8, 1989. Unpublished. Weihl C, Riley HD, Lapin JH. 1963. Extracted pertussis antigen: a clinical appraisal. American Journal of Diseases of Children 106:210-215. Weil ML, Itabashi HH, Cremer NE, Oshiro LS, Lennette EH, Carnay L. 1975. Chronic progressive panencephalitis due to rubella virus stimulating subacute sclerosing panencephalitis. New England Journal of Medicine 292:994-998. Weiss AA, Hewlett EL. 1986. Virulence factors of Bordetella pertussis. Annual Reviews of Microbiology 40:661-686. Weiss AA, Hewlett EL, Myers GA, Falkow S. 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infection and Immunity 42:33-41. Weiss AA, Hewlett EL, Myers GA, Falkow S. 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors in Bordetella pertussis. Journal of Infectious Diseases 150:219-222. Weiss NS. 1989. National Childhood Encephalopathy Study: potential biases related to case and control selection. Institute of Medicine Workshop on the National Childhood Encephalopathy Study, Washington, DC, November 7-8, 1989. Unpublished. Weller TH, Neva FA. 1962. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proceedings of the Society for Experimental Biology and Medicine 111:215-225. Wentz KR. 1989. Case definition in the National Childhood Encephalopathy Study: effect of inclusion of cases with other potential causes for case presentation. Institute of Medicine Workshop on the National Childhood Encephalopathy Study, Washington, DC, November 7-8, 1989. Unpublished. Wentz KR, Marcuse EK. 1991. Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence. Pediatrics 87:287-297. Werne J, Garrow I. 1946. Fatal anaphylactic shock occurrence in identical twins following second injection of diphtheria toxoid and pertussis antigen. Journal of the American Medical Association 131:730-735. Werner H, Strauss AA. 1941. Pathology of the figure-background relation in the child. Journal of Abnormal Social Psychology 36:236-248. Wetterlow LH, Edsall G. 1970. The effect of benzethonium chloride on the antigens of pertussis vaccine. International Archives of Allergy 37:143-153.

OCR for page 208
Page 280 White R, Finberg L, Tamer A. 1964. The modern morbidity of pertussis in infants. Pediatrics 33:705-710. Widelock D, Martorana NF, Schaeffer M. 1966. The effect of pertussis vaccine on fetal wastage in mice. II. The sparing effect of glucose. American Journal of Public Health 56:1588-1691. Wiedmeier SE, Chung HT, Cho BH, Kim UH, Daynes RA. 1987. Murine responses to immunization with pertussis toxin and bovine serum albumin. I. Mortality observed after bovine albumin challenge is due to an anaphylactic reaction. Pediatric Research 22:262-267. Wiener SL, Tinker M, Bradford WL. 1959. Experimental meningoencephalomyelitis produced by hemophilus pertussis. Archives of Pathology 67:694-699. Wiesenthal AM, Lauer BA. 1987. Syringe preparation technique and minor adverse reactions to diphtheria-tetanus-pertussis immunization. Pediatric Infectious Disease Journal 6:1048-1050. Wiggins CA, Dykewicz MS, Patterson R. 1989. Idiopathic anaphylaxis: a review. Annals of Allergy 62:1-4. Wilkins J. 1986. Pertussis agglutinogen: an immunogen and an allergen (letter). American Journal of Diseases of Children 140:507. Wilkins J. 1988. What is "significant" and DTP reactions (letter). Pediatrics 81:912. Wilkins J, Williams FF, Wehrle PF, Portnoy B. 1971. Agglutinin response to pertussis vaccine. I. Effect of dosage and interval. Journal of Pediatrics 79:197-202. Wilkins J, Chan S, Wehrle PF. 1987. Age and dose interval as factors in agglutinin formation to pertussis vaccine. Vaccine 5:49-54. Williams NM, Preblud SR. 1984. Rubella and congenital rubella surveillance, 1983. Centers for Disease Control Surveillance Summaries 33:1SS-10SS. Williams RM. 1969. Reactions to triple vaccines in infancy. The Medical Officer 122:274. Williams WO. 1981. Whooping cough in adults. British Medical Journal 283:1122. Williams WO, Jones B. 1987. Study of intellectual performance of children in ordinary schools after certain serious complications of whooping cough. British Medical Journal 295:1044-1047. Wing L. 1981. Sex ratios in early childhood autism and related conditions. Psychiatry Research 5:129. Wing L, Yeates SR, Brierley LM, Gould J. 1976. The prevalence of early childhood autism: comparison of administrative and epidemiological studies. Psychological Medicine 6:89-100. Wirsing von König CH, Hoppe JE, Tacken A, Finger H. 1990. Detection of Bordetella pertussis in clinical specimens. In: Manclark CR, ed. Sixth International Symposium on Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services. Witney EW. 1940. Neuritis following rubella (letter). British Medical Journal 1:831. Witte JJ, Karchmer AW, Case G, Herrmann KL, Abrutyn E, Kassanoff I, Neill JS. 1969. Epidemiology of rubella. American Journal of Diseases of Children 118: 107-112. Wolfe SM, ed. Questions and answers. Pertussis and pertussis vaccine: the "P" in DPT. Public Citizen Health Research Group. Health Letter 4:6-8.

OCR for page 208
Page 281 Wolff SM. 1973. Biological effects of bacterial endotoxins in man. Journal of Infectious Diseases 128(Suppl.):S259-S264. Woodbury LA. 1978. Incidence and prevalence of seizure disorders including the epilepsies in the United States of America: a review and analysis of the literature. In: Plan for Nationwide Action on Epilepsy, Vol. 4: The Commission for the Control of Epilepsy and its Consequences. DHEW Publication No. (NIH) 78-279. Washington, D.C.: U.S. Department of Health, Educaion, and Welfare. Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Nogimori K, Muzushima Y, Nakase Y, Ui M. 1978. Islet-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Journal of Biochemistry 83:295-303. Yamauchi T. 1986. The controversy in clinical medicine regarding the risks and benefits of pertussis immunization. Neurotoxicology 7:47-51. Yamasaki S. 1983. Side effects after improved DPT vaccine. Annales Paediatrici Japonici 29:24. Yannet H, Deamer WC, Barba PS. 1949. Convulsive disorders in children. Round Table Discussion, American Academy of Pediatrics. Pediatrics 4:677-680. Yannet H. 1951. The treatment and prognosis of convulsive disorders in children. Bulletin of the New York Academy of Medicine 27:466-474. Zahalsky AC. 1989a. Biological activities and properties of Bordetella pertussis toxins. May 1989. Unpublished. Zahalsky AC. 1989b. Some biochemical mechanisms and consequences of the joint action(s) of pertussis toxin and endotoxin in humans. June 1989. Unpublished. Zahalsky AC. 1989c. Neurotoxicity via permeability of cerebral capillaries. July 1989. Unpublished. Zahalsky AC. 1989d. A contributing mechanism to cell injury following inoculation with whole cell DTP vaccine (adsorbed): ADP-ribosylation by pertussis toxin as potential inhibitor of essential energy yielding reactions. October 1989. Unpublished. Zahalsky AC. 1990. Scientific basis for including tests of acute phase reaction products in clinical protocols designed to investigate the cause of adverse reactions following inoculation(s) in infants with DTP (ads.) vaccine. Institute of Medicine Public Meeting on Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, January 10, 1990. Unpublished. Zeffer KB, Sauer MV. 1988. Orchitis after a rubella vaccination: a case report. Journal of Reproductive Medicine 33:80-81. Zellweger H. 1959. Pertussis encephalopathy. Archives of Pediatrics 76:381-386. Zellweger H, Steinegger R. 1950. Zur Klinik und Pathogenese der Pertussisencephalopathie. Helvetica Paediatrica Acta 5:139. Zhang JM, Cowell JL, Steven AC, Carter PH, McGrath PP, Manclark CR. 1985a. Purification and characterization of fimbriae from Bordetella pertussis. Infection and Immunity 48:422-427. Zhang JM, Cowell JL, Steven AC, Manclark CR. 1985b. Purification of serotype 2 fimbrae of Bordetella pertussis and their identification as a mouse protective antigen. Developments in Biological Standardization 61:173-185. Zuelzer WW, Mastrangelo R, Stulberg CS, Poulik MD, Page RH, Thompson RI.

OCR for page 208
Page 282 1970. Autoimmune hemolytic anemia: natural history and viral-immunologic interactions in childhood. American Journal of Medicine 49:80-93. Zupanska B, Lawkowicz W, Gorska B, Kozlowska J, Ochocka M, Rokicka-Milewska R, Derulska D, Ciepielewska D. 1976. Autoimmune haemolytic anaemia in children. British Journal of Haematology 34:511-520.